PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larisa, Greece. thanoschalkias@yahoo.gr.\', \'Department of Cardiology, General Hospital of Paphos, Paphos, Cyprus.\', \'Department of Anesthesiology, Tzaneio General Hospital, Piraeus, Greece.\', \'School of Medicine, European University Cyprus, Nicosia, Cyprus.\', \'First Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.\', \'Department of Emergency Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larisa, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40291-020-00481-8
?:doi
?:hasPublicationType
?:journal
  • Molecular diagnosis & therapy
is ?:pmid of
?:pmid
?:pmid
  • 32613288
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all